Hepatocellular carcinoma associated with progressive intrahepatic familial cholestasis type 2: a case report
Progressive familial intrahepatic cholestasis type 2 (PFIC2) is an autosomal recessive disorder typically presenting in infancy with cholestasis and rapidly progressing to cirrhosis. PFIC has been associated with an elevated risk of hepatocellular carcinoma (HCC), a neoplasm that is uncommon in children. PFIC type 4 has the strongest link to this type of cancer, although a few cases have also been connected to PFIC2. Herein, we report the case of a 2-year-old boy who underwent liver transplantation due to PFIC2. Histological examination showed cirrhosis and four small HCCs. Over a 20-year period following the transplantation, there was no recurrence of the disease or HCC. Although rare, HCC development can occur in PFIC and may complicate the prognosis. Liver transplantation offers a potential cure for both the metabolic disease and the neoplasm.
Authors
- Ricardo Martins (ORCID: https://orcid.org/0000-0001-5340-7582)
- Rui Caetano Oliveira (ORCID: https://orcid.org/0000-0002-7202-8059)
- Maria Augusta Cipriano (ORCID: https://orcid.org/0000-0003-3736-0141)
- Susana Nobre (ORCID: https://orcid.org/0000-0001-6749-8681)
- João Miguel Pimentel (ORCID: https://orcid.org/0000-0002-0001-191X)
Institutions
- Instituto Português de Oncologia de Coimbra Francisco Gentil (PT)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- University of Coimbra (PT)
Publication Details
- Journal
- Clinical Transplantation and Research
- Published
- 2024-09-30
- DOI
- https://doi.org/10.4285/ctr.24.0016
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00